Morphine-6-glucuronide - ML Laboratories

Drug Profile

Morphine-6-glucuronide - ML Laboratories

Alternative Names: Isomorph; M6G - ML Laboratories

Latest Information Update: 17 Nov 2003

Price : $50

At a glance

  • Originator Unknown
  • Developer ML Laboratories
  • Class Morphine derivatives; Opioid analgesics
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer pain; Postoperative pain

Most Recent Events

  • 17 Nov 2003 Morphine-6-glucuronide is available for licensing outside of North America (
  • 16 Mar 1999 Phase-II clinical trials for Postoperative pain in United Kingdom (IV)
  • 16 Mar 1999 Phase-II clinical trials for Cancer pain in United Kingdom (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top